Finally, in Lewy body pathology, it seems that α-synuclein affects cognitive function at least partly by influencing tau pathology through interactions with molecules such as TNFR1 and ICAM-1 [65], and there may be a gradual development of AD pathology in patients initially harboring pure synucleinopathy [23]. This evidence concerns the gene MAPT and synucleinopathy.